The Kirby Institute at UNSW Sydney is part of a consortium to receive funding and will lead program implementation in the Indo-Pacific.
Researchers at The Kirby Institute will collaborate on a first-of-its-kind program to set Papua New Guinea and Vanuatu on a path to eliminating cervical cancer.
The new screening program for cervical cancer aims to save lives by breaking down barriers that prevent women from attending screening, write Karen Canfell and Megan Smith.
Researchers have found that in just four years the HPV vaccine has resulted in a dramatic drop in genital warts in young Australians of all backgrounds, a result that could herald good news for cervical cancer rates.
As the government considers recommendations for changes to cervical cancer screening, UNSW is a leading partner in a major trial of the new technology in Victoria.
Replacing two-yearly pap smears with five-yearly testing for the human papillomavirus (HPV) is expected to reduce cervical cancer rates even further, writes Karen Canfell.
Vaccination against the virus that causes cervical cancer has had an additional benefit - a marked decline in cases of genital warts, a new study has found.
HIV/AIDS and kidney transplant patients are at much greater risk of contracting 20 different types of cancer than the general population, according to UNSW research published in The Lancet.